XPECTRALTEK, LDA

Their core work

XpectralTEK is a Portuguese technology SME based in Braga that develops advanced optical and spectral sensing systems. Their applied commercial work centres on hyperspectral imaging for biomedical use — specifically non-invasive early diagnosis of retinal diseases through smart spectral analysis. In parallel, they contribute industry perspective to academic research consortia exploring terahertz photonics, chiral metamaterials, and graphene-based optical components. This dual track places them at the boundary between medical device development and frontier photonic materials science.

What they specialise in

How they've shifted over time

XpectralTEK's first H2020 project (2020) was firmly in applied optics for clinical use — developing a hyperspectral camera system to detect retinal disease non-invasively, a product-oriented feasibility study. By 2021 they had moved into a five-year fundamental research consortium focused on chiral metamaterials and terahertz physics, with no direct clinical application. This shift suggests the company is deliberately building deeper scientific capabilities in photonic materials, likely to underpin next-generation sensing products rather than abandoning their applied roots.

XpectralTEK appears to be building fundamental photonics depth through long-term academic collaboration, positioning itself to develop proprietary components for high-end optical and THz sensing systems in the coming years.

How they like to work

XpectralTEK has operated both as project leader (coordinator of the SME Phase 1 feasibility study XpeFundus) and as an industry partner embedded in a larger academic consortium (CHARTIST, MSCA-RISE). Their network of 12 partners across 8 countries is notably broad for a company with only two projects, indicating active engagement rather than passive participation. As an SME in an MSCA-RISE consortium they likely play the role of industrial end-user or technology transfer bridge — bringing commercial relevance to academic research.

XpectralTEK has built connections with 12 unique consortium partners across 8 countries within just two projects, suggesting a strong network for a small Portuguese SME. Their geographic spread is European, with no single country dominance visible from the available data.

What sets them apart

XpectralTEK occupies an unusual niche: a small commercial company that can both develop marketable optical diagnostics products and engage credibly in deep photonic materials research. Few SMEs at this funding scale manage to coordinate their own product-development project while simultaneously contributing to a five-year MSCA-RISE consortium on metamaterials. For consortium builders, they offer the combination of industrial application focus and genuine photonics technical depth that purely academic partners cannot provide.

Highlights from their portfolio

• XpeFundus
  XpectralTEK led this project as coordinator — a commercial feasibility study for a hyperspectral retinal diagnostics system that shows their capacity to drive product development, not just contribute to research.
• CHARTIST
  A 5-year MSCA-RISE project (2021–2026) on chiral metamaterials for THz polarisation control — XpectralTEK's largest funded project and evidence of recognition by an international photonics research consortium.